Mar 30, 2018 | Cancer Center News
Urbana, Ill. – Created by the Grainger College of Engineering, the Illinois Innovators podcast spotlights research, technological advances, and entrepreneurial efforts of students, faculty, and alumni at the University of Illinois Urbana-Champaign. In 2018, the...
Mar 29, 2018 | Cancer Center News
The Computational Genomics workshop co-sponsored by the Cancer Center, Coordinated Sciences Laboratory, and Carl R. Woese Institute for Genomic Biology on Friday, March 2, 2018 was a great success. Over 70 participants from departments across campus attended to hear...
Mar 28, 2018 | Cancer Center News
Image of Andrew Smith. University of Illinois at Urbana-Champaign researchers recently received a $1.8 million grant from the National Institutes of Health (NIH) to develop a new assay technology that could determine the effectiveness of cancer drug treatments and aid...
Mar 17, 2018 | Cancer Center News
This award is presented for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, the prevention of cancer, or the treatment of patients...
Mar 15, 2018 | Cancer Center News
Image of Assistant Professor Roy Dar. Bioengineering Assistant Professor Roy Dar received the Illinois Student Senate Teaching Excellence Award at the end of the spring 2018 semester. This award, which is run entirely by students, is presented each year to about 5...
Mar 14, 2018 | Cancer Center News
Cancer research is becoming more reliant on data, computing, software, and visualization. The National Center for Supercomputing Applications (NCSA) and the Cancer Center teamed up to discuss these issues on March 14, 2018. NCSA is a hub of transdisciplinary research...
Mar 8, 2018 | Cancer Center News
The research team of Anna Arthur (Assistant Professor – Food Science and Human Nutrition), Sylvia Crowder (C★STAR Research Assistant), and Kalika Sarma (Carle Cancer Center Oncologist) were published in the Journal of Cancer Epidemiology, Biomarkers &...
Mar 8, 2018 | Cancer Center News
ABSTRACT: Glioblastoma (GBM) is the most common, aggressive, and deadly form of adult brain cancer, and is associated with a short survival rate (median 12–15 months, 5+ year less than 5%). The complex tumor microenvironment includes matrix transitions at the tumor...
Mar 3, 2018 | Cancer Center News
Image of T-Cell. T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can’t match, but the field is still looking for a clear success. Last September, GlaxoSmithKline took over one of Adaptimmune Therapeutics’...
